Mastery EAQ Ch. 13

A  Onset after the age 7 years. Short attention span for the child’s age. Acting out during school or in the home

B  Onset after the age 7 years. Learning disability with signs of depression. Acting out during school or in the home

C  Symptoms lasting at least 6 months. Learning disability with signs of depression. Acting out during school or in the home

D  Lack of ability to control impulses. Symptoms lasting at least 6 months. Short attention span for the child’s age

A  Pain status

B  Activity level

C  Vital signs

D  Dietary intake

A  Respiratory rate of 16 breaths per minute

B  Carbon dioxide arterial blood gas levels increase

C  Responds to command to use incentive spirometer

D  Pulse of 98 beats per minute

A  Caffeine withdrawal

B  Rebound headache

C  Hangover effect

D  Serotonin syndrome

A  Onset of confusion, Slurred speech, Blood pressure of 168/94 mmHg, Two previous sumatriptan injections at 0800 and 1200

B  Onset of confusion, History of chronic headache, Blood pressure of 168/94 mmHg, Two previous sumatriptan injections at 0800 and 1200

C  Onset of confusion, Slurred speech, Blood pressure of 168/94 mmHg, History of chronic headache

D  Onset of confusion, Slurred speech, History of chronic headache, Two previous sumatriptan injections at 0800 and 1200

A  Schedule IV

B  Schedule I

C  Schedule II

D  Schedule III

A  Phenobarbitone

B  Diazepam

C  Morphine

D  Caffeine

A  Addiction

B  Suicidal tendencies

C  Mood swings

D  Sleeplessness

A  Atomoxetine

B  Orlistat

C  Sumatriptan

D  Caffeine

A  Atomoxetine

B  Amphetamine aspartate

C  Methylphenidate

D  Dextroamphetamine sulfate

A  Postanesthetic respiratory depression and Migraines

B  Postanesthetic respiratory depression and Bronchopulmonary dysplasia

C  Bronchopulmonary dysplasia and Migraines

D  End-stage heart failure and Peptic ulcer disease

A  Relaxes the bronchial smooth muscle. Increases sensitivity to carbon dioxide. Supports a regular pattern of breathing. Blocks the action of cerebral adenosine.

B  Promotes constriction of the bronchi. Blocks the action of cerebral adenosine. Increases the production of surfactant.

C  Promotes constriction of the bronchi. Increases the production of surfactant. Increases sensitivity to carbon dioxide.

D  Relaxes the bronchial smooth muscle. Promotes constriction of the bronchi. Increases the production of surfactant.

A  Modafinil for shift work sleep disorder

B  Atomoxetine for attention-deficit/hyperactivity disorder

C  Dextroamphetamine for narcolepsy

D  Orlistat for weight loss management

A  Early afternoon when restlessness occurs

B  At least 4 hours before bedtime

C  Before breakfast on weekdays

D  Preceding morning school activities daily

A  Supplement the diet with fat-soluble vitamins.

B  Limit dietary intake of fat to less than 30% of total calories.

C  Take the medication with an antacid.

D  Increase fluid and fiber in the diet.

A  Naratriptan

B  Phentermine

C  Orlistat

D  Modafinil

A  Do not take phentermine.

B  Take the medication with a lot of fluids.

C  Take acetaminophen.

D  Take ice chips for relief of headache.

A  Methylphenidate

B  Armodafinil

C  Amphetamine aspartate

D  Orlistat

A  Substance abuse treatment

B  Dietary referral

C  Respiratory therapy

D  Pain management

A  Talk to the health care provider about instituting “drug holidays.”

B  Reduce the dose of the medication slightly.

C  Use deep breathing exercises instead of medication to keep the child calm.

D  Switch the child to caffeine, which is a more natural stimulant.

A  “Your child has attention-deficit/hyperactivity disorder.”

B  “This is the normal behavior of a 7-year-old child.”

C  “You should continue to observe the child’s behavior for 4 months.”

D  “You should consult a child psychiatrist immediately.”

A  “Ask the primary health care provider to prescribe an oral hypoglycemic medication.”

B  “You should drink coffee and alcohol once a week to reduce obesity.”

C  “You should follow a nutrition and exercise regimen for weight management.”

D  “Ask the primary health care provider to prescribe an anorexiant because it will reduce obesity.”

A  The patient has taken the medication with excess amounts of fluids.

B  The patient has not followed the dosing schedule as prescribed.

C  The patient has been taking this medication for a long time.

D  The patient has been taking reduced doses of medication.

A  Methamphetamine

B  Benzphetamine

C  Orlistat

D  Phentermine

A  “This drug has many side effects.”

B  “This drug has a high risk of abuse.”

C  “This drug causes amenorrhea.”

D  “This drug causes hallucinations.”

A  Modafinil

B  Atomoxetine

C  Benzphetamine

D  Methylphenidate

A  Dextroamphetamine

B  Phentermine

C  Almotriptan

D  Caffeine

A  Atomoxetine and orlistat

B  Modafinil and sumatriptan

C  Doxapram and sumatriptan

D  Modafinil and doxapram

A  Administer the medication after meals. Administer the medication before sending the child to school. Administer the medication 2 hours before going to bed.

B  Avoid dissolving the sustained-release medications in water. Administer the medication after meals. Administer the medication 2 hours before going to bed.

C  Avoid administering medications on weekends. Avoid dissolving the sustained-release medications in water. Administer the medication before sending the child to school.

D  Administer the medication after meals. Administer the medication 2 hours before going to bed. Avoid administering medications on weekends.

A  “I will give these drugs 30 to 45 minutes before meals to improve absorption.”

B  “I may dispense these medications to nursing staff if needed.”

C  “It is permissible to crush extended-release medications for patients who have difficulty swallowing pills.”

D  “If I notice side effects of these medications, I should stop giving the drug immediately and notify the provider.”

A  Enhanced urinary output

B  Fecal incontinence

C  Chest congestion

D  Diarrhea

A  Diazepam and Ergotamine

B  Ergotamine and Sibutramine

C  Diazepam and Atomoxetine

D  Naratriptan and Zolmitriptan

A  The patient has diabetes.

B  The patient is taking monoamine oxidase inhibitors (MAOIs).

C  The patient has glaucoma.

D  The patient is taking antiviral medications.

A  Hypotension

B  Bradycardia

C  Decreased mental alertness

D  Insomnia

A  Increased blood pressure

B  Bradycardia

C  Drowsiness

D  Syncope

A  Dizziness, Numbness, Nasal irritation

B  Nasal irritation, Tingling, Flushing

C  Tingling, Dizziness, Flushing

D  Tingling, Flushing, Numbness

A  Insomnia

B  Nutrition deficiency

C  Hyperglycemia

D  Gastric ulcers

A  Dexmethylphenidate is contraindicated in pediatric patients.

B  Dexmethylphenidate does not improve attention.

C  Dexmethylphenidate has more addictive properties.

D  Dexmethylphenidate induces sedation in the child.

A  Daytime sleepiness, Photophobia, Skeletal muscle weakness

B  Pulsating headache, Daytime sleepiness, Skeletal muscle weakness

C  Phonophobia, Daytime sleepiness, Skeletal muscle weakness

D  Photophobia, Phonophobia, Pulsating headache

A  Insomnia, Headache, Weight loss

B  Increased appetite, Insomnia, Decreased blood pressure

C  Headache, Increased appetite, Decreased blood pressure

D  Weight loss, Increased appetite, Decreased blood pressure

A  Headache, Severe hypertension

B  Seizures, Insomnia, Dysrhythmias

C  Headache, Severe hypertension

D  Headache, Severe hypertension

A  Hypotension, Hypothyroidism, Glaucoma

B  Glaucoma, Drug allergies, Bulimia nervosa

C  Hypotension, Bulimia nervosa, Hypothyroidism

D  Drug allergies, Hypotension, Hypothyroidism

A  “They increase the effect of norepinephrine.”

B  “They block the reuptake of dopamine.”

C  “It may decrease my heart rate.”

D  “I should not take these medications at least 1 day per week.”

A  5 mg before breakfast and lunch

B  50 mg as a single dose

C  20 mg after lunch

D  120 mg at each meal

A  Orlistat

B  Modafinil

C  Dextroamphetamine

D  Sumatriptan

A  Serotonin receptor agonists

B  Phosphodiesterase inhibitors

C  Ergot alkaloids

D  Lipase inhibitors

A  Cerebrovascular system

B  Cerebral cortex

C  Hypothalamic and limbic regions

D  Medulla and brainstem

A  Doxapram

B  Aminophylline

C  Caffeine

D  Theophylline

A  100 mg

B  32 mg

C  40 mg

D  200 mg

A  To reduce blood pressure. To reduce blood glucose level.

B  To reduce blood glucose level. To reduce uric acid levels.

C  To reduce uric acid levels. To reduce blood pressure

D  To increase the rate of respiration. To increase the depth of respiration

A  Modafinil

B  Sumatriptan

C  Atomoxetine

D  Phentermine

A  Hyperactivity

B  Skeletal muscle weakness

C  Pulsating headache

D  High body mass index (BMI)

A  Attention-deficit/hyperactivity disorder

B  Migraine

C  Narcolepsy

D  Postanesthetic respiratory depression

A  Orlistat

B  Phentermine

C  Amphetamine

D  Atomoxetine